ATE18552T1 - Salze von alpha-amino(und imino)-saeure, omegasulfon n-substituiert, kationische vektoren mit hoher cellularer penetration und herstellungsverfahren. - Google Patents

Salze von alpha-amino(und imino)-saeure, omegasulfon n-substituiert, kationische vektoren mit hoher cellularer penetration und herstellungsverfahren.

Info

Publication number
ATE18552T1
ATE18552T1 AT83401373T AT83401373T ATE18552T1 AT E18552 T1 ATE18552 T1 AT E18552T1 AT 83401373 T AT83401373 T AT 83401373T AT 83401373 T AT83401373 T AT 83401373T AT E18552 T1 ATE18552 T1 AT E18552T1
Authority
AT
Austria
Prior art keywords
omegasulfone
imino
alpha
salts
amino
Prior art date
Application number
AT83401373T
Other languages
German (de)
English (en)
Inventor
Jean Pierre Durlach
Original Assignee
Meram Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meram Lab filed Critical Meram Lab
Application granted granted Critical
Publication of ATE18552T1 publication Critical patent/ATE18552T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
AT83401373T 1982-07-05 1983-07-04 Salze von alpha-amino(und imino)-saeure, omegasulfon n-substituiert, kationische vektoren mit hoher cellularer penetration und herstellungsverfahren. ATE18552T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8211768A FR2529546A1 (fr) 1982-07-05 1982-07-05 Nouveaux sels d'amino-(et imino-)acides a, o-sulfoniques n-substitues, vecteurs cationiques de haute penetration cellulaire
EP83401373A EP0099799B1 (fr) 1982-07-05 1983-07-04 Nouveaux sels d'amino- (et imino-) acides alpha, omega-sulfoniques N-substitués, vecteurs cationiques de haute pénétration cellulaire, procédé d'obtention

Publications (1)

Publication Number Publication Date
ATE18552T1 true ATE18552T1 (de) 1986-03-15

Family

ID=9275686

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83401373T ATE18552T1 (de) 1982-07-05 1983-07-04 Salze von alpha-amino(und imino)-saeure, omegasulfon n-substituiert, kationische vektoren mit hoher cellularer penetration und herstellungsverfahren.

Country Status (8)

Country Link
US (1) US4563470A (enExample)
EP (1) EP0099799B1 (enExample)
JP (1) JPS6055067B2 (enExample)
AT (1) ATE18552T1 (enExample)
DE (1) DE3362536D1 (enExample)
ES (1) ES523839A0 (enExample)
FR (1) FR2529546A1 (enExample)
PT (1) PT76970B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0010099A (pt) * 1999-04-28 2002-06-04 Univ Kingston Métodos para modular a agregação de amilóides em um indivìduo, para o tratamento de um estado doentio associado com amiloidose, composição para modular amiloidose, e, métodos para inibir os depósitos de amilóide associados com iapp em um indivìduo, para inibir fibrilogenese iapp em um indivìduo, para reduzir os agregados de amilóides associados com iapp em um indivìduo, para modular dano associado com amilóides em células, e para modular amiloidose in vivo ou ex vivo
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) * 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7244764B2 (en) * 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
EP1828111A2 (en) * 2004-11-12 2007-09-05 Neurochem (International) Limited Methods and fluorinated compositions for treating amyloid-related diseases
CA2586334A1 (en) * 2004-11-16 2006-06-08 Neurochem (International) Limited Compounds for the treatment of cns and amyloid associated diseases
US8044100B2 (en) * 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
EP2862581B1 (en) 2006-10-12 2021-08-11 BHI Limited Partnership Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

Also Published As

Publication number Publication date
PT76970A (fr) 1983-07-01
PT76970B (fr) 1986-01-24
FR2529546B1 (enExample) 1985-02-08
EP0099799B1 (fr) 1986-03-12
ES8403873A1 (es) 1984-04-01
EP0099799A1 (fr) 1984-02-01
US4563470A (en) 1986-01-07
JPS5921666A (ja) 1984-02-03
JPS6055067B2 (ja) 1985-12-03
ES523839A0 (es) 1984-04-01
FR2529546A1 (fr) 1984-01-06
DE3362536D1 (en) 1986-04-17

Similar Documents

Publication Publication Date Title
FI875059L (fi) Foereningar.
ES2061432T3 (es) Nuevas amidas de acido acrilico.
PT99556A (pt) Processo para a preparacao de novos compostos poliazamacrociclicos para a complexacao de metais
ATE18552T1 (de) Salze von alpha-amino(und imino)-saeure, omegasulfon n-substituiert, kationische vektoren mit hoher cellularer penetration und herstellungsverfahren.
DE3372287D1 (en) Process for the preparation of tetrahydropyridines
GR79484B (enExample)
ES8102058A1 (es) Procedimiento para la obtencion de suspensiones acuosas de zeolita estables
GB1285610A (en) Quinacridone pigments
ES525508A0 (es) Procedimiento para el compactado de oxido anodicas sobre aluminio y sus aleaciones
DE2963675D1 (en) A process for inverting the configuration in optically active compounds and optically active intermediate compounds and their salts required therefor
ES8406057A1 (es) Procedimiento para la preparacion de una solucion acuosa de cianamida estabilizada.
GB986580A (en) 5-substituted dibenzocycloheptadienes
DE3665712D1 (en) Heterocyclic amide derivatives
ES449951A1 (es) Metodo de proteccion de las paredes de intercambio contra laincrustacion.
JPS57149474A (en) Corrosion inhibitor for cuppric metal
ES522675A0 (es) Un compuesto de imidazolilpropanol opticamente activo.
DE3585346D1 (de) Lithium- und ammoniumsalze von poly(acrylamidomethylpropansulfonsaeure) und deren verwendung als verdickungsmittel in stark polaren organischen loesungsmitteln.
GB1091178A (en) Phthalocyanine dyestuffs
HUT42083A (en) Herbicides containing azolides of kynolin-8-carbonic acid and process for production of the active substance
GB1139558A (en) Dyeing auxiliaries
GB941998A (en) Method of hardening gelatine
CA1231973A (en) META- AND PARA-ISOPROPENYL-.alpha.,.alpha.-DIMETHYLBENZYLAMINE
ES360860A1 (es) Procedimiento para la preparacion de nuevos derivados de tiazepina.
GB1027755A (en) S-vinylthiamine derivatives
JPS5283829A (en) Cyclic compound

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee